RSPH ETF Analysis: SP500 Equal Weight Health | NYSE
Healthcare Equity | NYSE, USA | Market Cap: 995m USD | 12M Return: 36.4% | US46137V3327 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 12.5M
Warnings
No concerns identified
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The Invesco S&P 500 Equal Weight Health Care ETF (RSPH) is designed to track the performance of the health care sector within the S&P 500 Index on an equal-weighted basis. Under its investment policy, the fund commits at least 90% of its total assets to the securities that make up the underlying index, which consists of S&P 500 constituents classified under the health care sector per the Global Industry Classification Standard (GICS).
As an equal-weight fund, RSPH allocates the same proportional weight to each index constituent, rather than weighting holdings by market capitalization. The GICS health care sector broadly encompasses pharmaceutical companies, biotechnology firms, medical device manufacturers, health care providers, and health insurers, giving the fund diversified exposure across these sub-industries.
- Drug pricing reform threatens pharma profit margins
- Interest rate cuts pressure high-multiple healthcare valuations
- Medicare reimbursement policies shift under new administration
As of November 11, 2026, the stock is trading at USD 41.27 with a total of 657,045 shares traded. Over the past week, the price has changed by +3.23%, over one month by +8.89%, over three months by +14.77% and over the past year by +36.39%.
Current recommended Stop Loss: 40.30 (which is 2.4% or 1.3 ATR below the current price).
SP500 Equal Weight Health has no consensus analysts rating.